SCHEMBL1388264

SCHEMBL1388264

C1=C(COc2ccccc2)CCN(Cc2nc3ccccc3[nH]2)C1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 8/20 0.65
NPC1 O15118 6/20 0.57
RAB9A P51151 5/20 0.57
SMN1; SMN2 Q16637 4/20 0.57
TP53 P04637 1/20 0.57
TSHR P16473 1/20 0.57
HTT P42858 1/20 0.52
EGFR P00533 1/20 0.50
ERBB2 P04626 1/20 0.50
HPGD P15428 1/20 0.50
DRD2 P14416 2/20 0.49
DRD3 P35462 1/20 0.49
GAA P10253 1/20 0.47
GRIN1 Q05586 1/20 0.47
GRIN2B Q13224 1/20 0.47
KMT2A Q03164 1/20 0.47
POLB P06746 1/20 0.47
TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1388041 0.85 DRD4 (0.69) DRD4NPC1HTTHPGDDRD2
SCHEMBL1388460 0.82 DRD4 (0.67) DRD4NPC1RAB9AHTTHPGD
SCHEMBL1388288 0.80 DRD4 (0.65) DRD4NPC1RAB9AHTTHPGD
SCHEMBL1388193 0.80 DRD4 (0.65) DRD4NPC1HTTHPGDDRD2
SCHEMBL1388197 0.79 DRD4 (1.00) DRD4HTTHPGDDRD2DRD3
SCHEMBL15004236 0.77 NPC1 (0.49) NPC1RAB9ASMN1; SMN2TP53HTT
SCHEMBL1388159 0.76 DRD4 (0.66) DRD4NPC1HTTHPGDDRD2
Hydrochloric Acid SCHEMBL8543107 0.76 DRD4 (0.65) DRD4NPC1HTTHPGDDRD2
SCHEMBL9091262 0.75 BCHE (0.56) DRD4RAB9ASMN1; SMN2TSHRHTT
SCHEMBL2241896 0.75 RAB9A (1.00) NPC1RAB9ASMN1; SMN2TP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235572-A2 METHOD TO TREAT PAIN UTILIZING BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS MERCK SHARP & DOHME LTD. (GB) 2002-09-04 EP claimed
US-6362196-B1 N-METHYLASPARATIC ACID ANTAGONIST MERCK & CO., INC. 2002-03-26 US claimed
WO-2001030330-A2 METHOD TO TREAT PAIN UTILIZING BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS MERCK SHARP & DOHME LIMITED (GB) 2001-05-03 WO claimed
EP-0689535-B1 BENZIMIDAZOLE DERIVATIVES MERCK SHARP & DOHME (GB) 1998-09-23 EP claimed
JP-H08508030-A 1996-08-27 JP claimed
EP-0689535-A1 BENZIMIDAZOLE DERIVATIVES MERCK SHARP & DOHME LTD. (GB) 1996-01-03 EP claimed
WO-1994021615-A1 BENZIMIDAZOLE DERIVATIVES MERCK SHARP & DOHME LIMITED (GB) 1994-09-29 WO claimed
EP-1235572-A2 METHOD TO TREAT PAIN UTILIZING BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS MERCK SHARP & DOHME LTD. (GB) 2002-09-04 EP disclosed
US-6362196-B1 N-METHYLASPARATIC ACID ANTAGONIST MERCK & CO., INC. 2002-03-26 US disclosed
WO-2001030330-A2 METHOD TO TREAT PAIN UTILIZING BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS MERCK SHARP & DOHME LIMITED (GB) 2001-05-03 WO disclosed
EP-0689535-B1 BENZIMIDAZOLE DERIVATIVES MERCK SHARP & DOHME (GB) 1998-09-23 EP disclosed
US-5714498-A Benzimidazole derivatives MERCK, SHARP, & DOHME, LTD. (GB) 1998-02-03 US disclosed
EP-0689535-A1 BENZIMIDAZOLE DERIVATIVES MERCK SHARP & DOHME LTD. (GB) 1996-01-03 EP disclosed
WO-1994021615-A1 BENZIMIDAZOLE DERIVATIVES MERCK SHARP & DOHME LIMITED (GB) 1994-09-29 WO disclosed